和佳医疗,300273,收入构成,报告日期,2020-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗设备及医用工程,26478,13699,12779,48.26%,56.85% 医疗金融业务,11345,5398,5947,52.42%,26.46% 医疗服务及专业咨询服务,3399,699,2700,79.43%,12.01% 其他(补充),1051,0,1051,100%,4.67% 和佳医疗,300273,收入构成,报告日期,2019-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗金融业务,27386,11727,15659,57.18%,26.43% 医疗信息化产品,3248,1163,2086,64.21%,3.52% 医疗服务及专业咨询服务,6206,1908,4298,69.25%,7.25% 医疗设备及医用工程,82932,45717,37214,44.87%,62.8% 其他,2055,-- ,-- ,--,0% 和佳医疗,300273,收入构成,报告日期,2019-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗服务及专业咨询服务,2079,495,1584,76.21%,5.17% 医疗设备及医用工程,42399,22569,19830,46.77%,64.68% 医疗信息化产品,2375,561,1815,76.39%,5.92% 其他(补充),402,-- ,-- ,--,0% 医疗金融业务,12765,5337,7428,58.19%,24.23% 和佳医疗,300273,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗服务及专业咨询服务,4570,361,4209,92.11%,7.19% 医疗金融业务,23081,7756,15324,66.4%,26.16% 医疗设备及医用工程,84820,49014,35806,42.21%,61.13% 其他(补充),2946,-- ,-- ,--,0% 医疗信息化产品,4184,955,3230,77.19%,5.51% 和佳医疗,300273,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医疗金融业务,13391,4575,8816,65.84%,31.62% 其他(补充),354,-- ,-- ,--,0% 医疗信息化产品,2906,910,1996,68.67%,7.16% 医疗服务及专业咨询服务,1705,7,1698,99.61%,6.09% 医疗设备及医用工程,33283,17914,15370,46.18%,55.13% 和佳医疗,300273,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 常规诊疗设备,2770,1612,1158,41.8%,1.95% 其他(补充),2894,1,2893,99.97%,4.87% 融资租赁收入,19656,5132,14523,73.89%,24.45% 代理产品,24974,17491,7482,29.96%,12.6% 医用制氧设备及工程,40441,21676,18765,46.4%,31.59% 肿瘤微创治疗设备,12603,2774,9829,77.99%,16.54% 医疗信息产品,1030,276,754,73.21%,1.27% 配件,6815,2811,4004,58.75%,6.74% 和佳医疗,300273,收入构成,报告日期,2017-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1143,-- ,-- ,--,0% 代理产品,10945,7274,3671,33.54%,18.01% 其他,2569,1007,1561,60.79%,7.66% 医疗信息产品,312,120,192,61.56%,0.94% 常规诊疗设备,886,609,277,31.22%,1.36% 融资租赁收入,7569,1802,5767,76.19%,28.3% 肿瘤微创治疗设备,5903,1658,4245,71.92%,20.84% 医用制氧设备及工程,11690,7028,4662,39.88%,22.88% 和佳医疗,300273,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),2394,68,2326,97.16%,4.7% 代理产品,20267,13617,6650,32.81%,13.45% 配件,4828,2378,2450,50.75%,4.95% 医疗信息产品,2572,676,1896,73.7%,3.83% 常规诊疗设备,2542,1464,1078,42.4%,2.18% 融资租赁,13440,4164,9276,69.02%,18.76% 肿瘤微创治疗设备,13207,2895,10311,78.08%,20.85% 医用制氧设备及工程,32672,17213,15459,47.31%,31.26% 和佳医疗,300273,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),668,-- ,-- ,--,0% 代理产品,10401,5914,4487,43.14%,18.99% 其他,859,500,358,41.72%,1.52% 医疗信息产品,935,360,575,61.53%,2.43% 常规诊疗设备,1259,828,431,34.26%,1.83% 融资租赁收入,6928,1410,5518,79.64%,23.35% 肿瘤微创治疗设备,6404,1766,4638,72.42%,19.63% 医用制氧设备及工程,19028,11406,7622,40.06%,32.26% 和佳医疗,300273,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他,1995,0,1994,99.98%,4.08% 代理产品,11297,5661,5636,49.89%,11.54% 配件,2145,762,1383,64.47%,2.83% 医疗信息产品,2574,846,1728,67.14%,3.54% 常规诊疗设备,4439,1869,2570,57.9%,5.26% 融资租赁咨询,4026,416,3610,89.66%,7.39% 融资租赁,6831,3125,3706,54.25%,7.59% 肿瘤微创治疗设备,22361,5439,16923,75.68%,34.65% 医用制氧设备及工程,23437,12146,11291,48.18%,23.12% 和佳医疗,300273,收入构成,报告日期,2015-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 代理产品,7027,3436,3591,51.1%,12.55% 常规诊疗设备,1633,956,677,41.43%,2.36% 医用分子筛制氧设备及工程,18818,9223,9594,50.99%,33.53% 其他,1260,650,610,48.38%,2.13% 融资租赁,4607,515,4092,88.83%,14.3% 其他(补充),943,-- ,-- ,--,0% 医疗信息产品,1440,383,1058,73.44%,3.7% 肿瘤微创治疗设备,11228,2232,8995,80.12%,31.43% 和佳医疗,300273,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 医用分子筛制氧设备及工程,30779,15555,15224,49.46%,25.88% 常规诊疗设备,4261,1589,2672,62.72%,4.54% 其他,6734,2053,4681,69.52%,7.96% 融资租赁,4658,574,4084,87.68%,6.94% 代理产品,14582,7004,7578,51.97%,12.88% 其他(补充),1012,1,1011,99.91%,1.72% 医疗信息产品,2238,665,1573,70.3%,2.67% 肿瘤微创治疗设备,28721,6722,21999,76.6%,37.4% 和佳医疗,300273,收入构成,报告日期,2014-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),325,-- ,-- ,--,0% 代理产品,5056,2613,2444,48.33%,10.05% 其他,868,462,406,46.77%,1.67% 常规诊疗设备,1541,948,593,38.49%,2.44% 医疗信息化,2089,599,1490,71.34%,6.13% 融资租赁服务,3820,449,3371,88.24%,13.86% 医用制氧系统及工程,17198,9612,7586,44.11%,31.18% 肿瘤微创治疗设备,10666,2229,8437,79.1%,34.68% 和佳医疗,300273,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),1851,-- ,-- ,--,0% 代理产品,11237,6296,4941,43.97%,6.08% 融资租赁,880,-- ,-- ,--,0% 其中:其他,2756,942,1814,65.82%,2.23% 其中:常规诊疗设备,4157,1783,2374,57.1%,2.92% 其中:制氧系统及工程,21379,12460,8919,41.72%,10.98% 其中:肿瘤微创治疗设备,31702,6678,25024,78.94%,30.82% 自产产品,59995,21863,38132,63.56%,46.96% 和佳医疗,300273,收入构成,报告日期,2013-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),82,-- ,-- ,--,0% 代理产品,4645,2988,1657,35.68%,9.54% 其他,875,607,268,30.67%,1.55% 常规诊疗设备,1629,1044,586,35.94%,3.37% 医用制氧设备及工程,10329,6870,3459,33.49%,19.93% 肿瘤微创治疗设备,14513,3122,11391,78.49%,65.61% 和佳医疗,300273,收入构成,报告日期,2012-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),678,-- ,-- ,--,0% 代理产品,6609,4925,1684,25.48%,5.38% 其他,1161,536,625,53.82%,1.99% 常规诊疗设备,6006,3221,2785,46.37%,8.89% 医用制氧设备及工程,17364,11677,5687,32.75%,18.15% 肿瘤微创治疗设备,27093,6543,20550,75.85%,65.59% 和佳医疗,300273,收入构成,报告日期,2012-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 常规诊疗设备,3154,1945,1208,38.31%,8.45% 肿瘤微创治疗设备,13228,2944,10284,77.75%,71.96% 其他,458,340,118,25.79%,0.83% 其他(补充),235,-- ,-- ,--,0% 代理产品,2493,2063,430,17.24%,3.01% 医用分子筛制氧设备及工程,7791,5540,2251,28.9%,15.75% 和佳医疗,300273,收入构成,报告日期,2011-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),577,4,573,99.28%,2.31% 代理产品,10225,8209,2016,19.72%,8.12% 其他,1094,762,332,30.37%,1.34% 常规诊疗设备,5695,3189,2506,44%,10.09% 医用制氧设备及工程,11752,7945,3806,32.39%,15.33% 肿瘤微创治疗设备,19532,3939,15593,79.83%,62.81% 和佳医疗,300273,收入构成,报告日期,2011-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),49,3,47,94.14%,0.22% 设备代理经销,4356,3846,510,11.71%,2.44% 其中:其他,673,543,130,19.38%,0.62% 其中:常规诊疗设备,3258,2068,1190,36.52%,5.7% 其中:医用分子筛制氧设备及工程,3497,2300,1197,34.23%,5.73% 其中:肿瘤微创治疗设备,9405,1762,7643,81.27%,36.61% 自产设备,16833,6672,10160,60.36%,48.67% 和佳医疗,300273,收入构成,报告日期,2010-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),90,6,85,93.63%,0.24% 设备代理经销,4386,3918,468,10.66%,1.35% 其中:其他,653,562,90,13.81%,0.26% 其中:常规诊疗设备,3043,1766,1276,41.94%,3.68% 其中:医用分子筛制氧设备及工程,9763,6531,3233,33.11%,9.33% 其中:肿瘤微创治疗设备,15437,2988,12449,80.64%,35.93% 自产设备,28895,11847,17048,59%,49.2% 和佳医疗,300273,收入构成,报告日期,2009-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),350,34,317,90.37%,1.33% 设备代理经销,5612,4965,648,11.54%,2.73% 其中:其他,436,415,21,4.76%,0.09% 其中:常规诊疗设备,2196,1105,1090,49.66%,4.59% 其中:医用分子筛制氧设备及工程,5406,3672,1734,32.07%,7.3% 其中:肿瘤微创治疗设备,10342,1796,8545,82.63%,35.99% 自产设备,18379,6989,11390,61.97%,47.97% 和佳医疗,300273,收入构成,报告日期,2008-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 其他(补充),220,14,207,93.72%,1.12% 设备代理经销,5870,4689,1180,20.11%,6.41% 其中:其他,427,148,279,65.34%,1.51% 其中:常规诊疗设备,1759,699,1060,60.26%,5.75% 其中:医用分子筛制氧设备及工程,2537,1373,1164,45.87%,6.31% 其中:肿瘤微创治疗设备,6988,969,6018,86.13%,32.66% 自产设备,11711,3190,8521,72.76%,46.24%